The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Deciphera; Syros Pharmaceuticals; Takeda (I)
Stock and Other Ownership Interests - Deciphera; Takeda (I)

An open label, multicenter, phase 1b/2 study of rebastinib (DCC-2036) in combination with carboplatin to assess safety, tolerability, and pharmacokinetics in patients with advanced or metastatic solid tumors.
 
Anthony W. Tolcher
Employment - Next Oncology; START
Leadership - Symphogen
Consulting or Advisory Role - AbbVie (Inst); Adagene (Inst); ADC Therapeutics (Inst); Agenus (Inst); Aro BioTX (Inst); Ascentage Pharma (Inst); Aximmune (Inst); Bayer (Inst); BioInvent (Inst); BioInvent (Inst); Birdie Bio (Inst); Boston Biomedical (Inst); EMD Serono (Inst); Forbius (Inst); HBM Partners (Inst); Ignyta (Inst); Immunome (Inst); Immunome (Inst); Jazz Pharmaceuticals (Inst); Mekanistic Therapeutics (Inst); Nanobiotix (Inst); NBE Therapeutics (Inst); Nuvalent, Inc. (Inst); Pelican Therapeutics (Inst); Pfizer (Inst); Pierre Fabre (Inst); Ridgeway (Inst); Scientex (Inst); Seagen (Inst); Sesen Bio (Inst); Symphogen (Inst); Syneos Health (Inst)
Research Funding - AbbVie (Inst); Adagene (Inst); ADC Therapeutics (Inst); Aminex (Inst); Arrys Therapeutics (Inst); Asana Biosciences (Inst); Ascentage Pharma (Inst); Birdie Biomedical (Inst); CStone Pharmaceuticals (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Inhibrx (Inst); Innate Pharma (Inst); Kiromic (Inst); Mersana (Inst); Naturewise (Inst); NextCure (Inst); Nitto BioPharma (Inst); Pfizer (Inst); Pieris Pharmaceuticals (Inst); Symphogen (Inst); Syndax (Inst); Tizona Therapeutics, Inc. (Inst); Zymeworks (Inst)
 
Pamela N. Munster
Stock and Other Ownership Interests - OncoSec (I)
Honoraria - Amgen (I); Prometheus (I); Threshold Pharmaceuticals
Consulting or Advisory Role - HUYA Bioscience International
Research Funding - Andes Biotechnologies (Inst); Biomarin (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Immune Design (Inst); Intellikine (Inst); Merck (Inst); Merrimack (Inst); Nektar (Inst); Novartis (Inst); OncoMed (Inst); Onconova Therapeutics (Inst); oncosec (Inst); Pfizer (Inst); Piramal Life Science (Inst); Plexxikon (Inst); Sanofi (Inst)
 
Lee S. Rosen
Research Funding - Bayer (Inst); Lilly (Inst); Pfizer (Inst); PsiOxus Therapeutics (Inst); Regeneron (Inst)
 
Curran Murphy
No Relationships to Disclose
 
Christian Argueta
Employment - Deciphera; Evelo Therapeutics (I); Karyopharm Therapeutics; Momenta Pharmaceuticals (I)
Stock and Other Ownership Interests - Karyopharm Therapeutics; Momenta Pharmaceuticals (I)
 
Keisuke Kuida
Employment - Deciphera
Stock and Other Ownership Interests - Deciphera; Vertex
 
Rodrigo Ruiz-Soto
Employment - Deciphera
Stock and Other Ownership Interests - Deciphera; Immunogen
Patents, Royalties, Other Intellectual Property - I am an inventor in 3 patents with Immunogen, I transferred the rights to Immunogen. I have not received (and I will not receive) any royalties
 
Filip Janku
Stock and Other Ownership Interests - Trovagene
Consulting or Advisory Role - Deciphera; Foundation Medicine; Guardant Health; IFM Therapeutics; Immunome; Novartis; PureTech; Sequenom; Sotio; Synlogic; Trovagene; Valeant/Dendreon
Research Funding - Agios (Inst); Asana Biosciences (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); Fujifilm (Inst); Novartis (Inst); Piqur (Inst); Plexxikon (Inst); Roche (Inst); Symphogen (Inst)
Other Relationship - Bio-Rad